Andrew Bell

Andrew is a Partner at Novasecta and joined the team through the acquisition of Strategy in Life Sciences (SiLS), where he was the Founder and Managing Director. Andrew has gained consulting experience from working with a wide range of pharmaceutical and biotech companies on their critical strategy issues, which includes commercial and corporate strategy development, business plan development, merger and acquisition advice and portfolio development. Prior to establishing SiLS, Andrew was an Executive Director at AVOS Consulting where he helped to establish a European healthcare consulting practice. His previous consulting experience also includes positions at Charles River Associates, IMS Consulting and L.E.K. Consulting.